This study is divided two parts into: Part A and Part B. Part A will recruit 24 research participants, and Part B will recruit 16 research participants.
Inclusion Criteria:
Exclusion Criteria:
zhouhuanbest@vip.163.com13665527160
Subjects will receive a single dose of D-2570
Subjects will receive a single dose of D-2570 (Part B)
Subjects will receive a single dose of D-2570 (Part A)
Subjects will receive a single dose of D-2570 (Part A)
dingli.yao@inventisbio.com15538261075
A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function
PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function
A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010
PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
A Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics (PK) of RO7079901
A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions
Renal Impairment Study of PF-06700841